Apheresis of immune diseases and apheresis using immunological specificity

Therapeutic Apheresis

Volumn 6, Issue 5, 2002, Pages 358-364

  Yagihashi, A ^a   Kikuchi, K ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Immune disorder; Immunoadsorption; Immunological specificity; Leukocytapheresis; Therapeutic apheresis

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; APHERESIS; AUTOIMMUNE DISEASE; CYTAPHERESIS; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOPATHOLOGY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; REVIEW;

AUTOIMMUNE DISEASES; B-LYMPHOCYTES; BLOOD COMPONENT REMOVAL; CYTOKINES; EXTRACORPOREAL CIRCULATION; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOSORBENT TECHNIQUES; NEOPLASMS; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 0036799121     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00451.x     Document Type: Review

References (28)

1. Nakaji S. Current topics on immunoadsorption therapy. Ther Apher 2001;5:301-5.
2. Hehmke B, Salzsieder E, Matic GB, Winkler RE, Tiess M, Ramlow W. Immunoadsorption of immunoglobulins alters intracytoplasmic type 1 and type 2 T cell cytokine production in patients with refractory autoimmune diseases. Ther Apher 2000;4:296-302.
3. Kondoh T, Hidaka Y, Katoh H, Inoue N, Saito S. Evaluation of a filtration lymphocytapheresis (LCP) device for use in the treatment of patients with rheumatoid arthritis. Artif Organs 1991;15:180-8.
4. Shimmura H, Tanabe K, Ishikawa N, Tokumoto T, Fuchinoue S, Takahashi K, Toma H, Agishi T. Removal of anti-A/B antibodies with plasmapheresis in ABO-incompatible kidney transplantation. Ther Apher 2000;4:395-8.
5. Agishi T, Kaneko I, Hasuo Y, Hayasaka Y, Sanaka T, Ota K, Amemiya H, Sugino N, Abe M, Ono T, Kawai S, Yamane T. Double filtration plasmapheresis. Trans Am Soc Artif Intern Organs 1980;26:406-11.
6. Kawagishi N, Ohkohchi N, Fujimori K, Orii T, Koyamada N, Kikuchi H, Sekiguchi S, Tsukamoto S, Sato T, Satomi S. Antibody elimination by apheresis in living donor liver transplant recipients. Ther Apher 2001;5:449-54.
7. Ernst C, Thurin J, Atkinson B, Wurzel H, Herlyn M, Stromberg N, Civin C, Koprowski H. Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am J Pathol 1984;117:451-61.
8. Stegmayr BG. Apheresis as therapy for patients with severe sepsis and multiple organ dysfunction syndrome. Ther Apher 2001;5:123-7.
9. Takahira S, Kanno Y, Okada H, Sugahara S, Nakamoto H, Suzuki H. Improved outcome prediction for patients with multiple organ failure undergoing continuous hemodiafiltration. Ther Apher 2001;5:31-5.
10. Porcu P, Farag S, Marcucci G, Cataland SR, Kennedy MS, Bissell M. Leukocytapheresis for acute leukemia. Ther Apher 2002;6:15-23.
11. Oliven A, Shechter Y. Extracorporeal photopheresis: a review. Blood Rev 2001;15:103-8.
12. Petrie HT, Klassen LW, Kay D. Inhibition of human cytotoxic lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 1985;134:230-4.
13. Shau H, Kim A. Suppression of lymphokine activated killer induction by neutrophils. J Immunol 1988;141:4395-402.
14. Segawa K, Ueno Y, Kataoka T. In vivo tumor growth enhancement by granulocyte colony-stimulating factor. Jpn J Cancer Res 1991;82:440-7.
15. Tabuchi T, Ubukata H, Sato S, Nakata I, Goto Y, Watanabe Y, Hashimoto T, Mizuta T, Adachi M, Soma T. Granulocytapheresis is a possible cancer treatment. Anticancer Res 1995; 15:985-90.
16. Tani T, Kodama M, Oka T, Hanasawa K, Teramoto K, Nishiumi S. Efficacy and biocompatibility of a novel anti-cancer fiber in hemoperfusion on cancer-bearing rabbits. Trans Am Soc Artif Organs 1984;30:308-12.
17. Onodera H, Abe Y, Yoshida M, Yamawaki N, Yamashita Y, Matsuo H, Ichinose K, Otsuru I, Shibuya N. A new device for selective removal of CD4+ T cells. Ther Apher 1998;2:37-42.
18. Goto H, Matsuo H, Nakane S, Izumoto H, Fukudome T, Kambara C, Shibuya N. Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes. Ther Apher 2001;5:494-6.
19. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nature Immunol 2001;2:816-22.
20. Bach JF. Non-Th2 regulatory T-cell control of Th1 autoimmunity. Scand J Immunol 2001;54:21-9.
21. Lu L, Thomson AW. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease. Transplantation 2002;73:19-22.
22. Wan Y, Bramson J. Role of dendritic cell-derived cytokines in immune regulation. Curr Pharm Des 2001;7:977-92.
23. Mitzner SR, Freytag J. Sauer M, Kleinfeldt T, Altrichter J, Klohr S, Koball S, Stange J, Ringel B, Nebe B, Schmidt H, Podbielski A, Noeldge-Schomburg G, Schmidt R. Use of human preconditioned phagocytes for extracorporeal immune support: introduction of a concept. Ther Apher 2001;5:423-32.
24. Lawrence DA, McCabe MJ. Immunomodulation by metals. Int Immunopharmacol 2002;2:293-302.
25. Van Kerckhove C. Lupus erythematosus in childhood: Effect of maternal factors beyond neonatal disease'? Clin Rheumatol 1990;9:168-70.
26. Greeley S, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji A, Noorchashm H. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat Med 2002;8:399-402.
27. Ibs KH, Rink L. The immune system in aging. Z Gerontol Geriatr 2001:34:480-5.
28. Beretta A, Hasson H, Samiabadi A, Alfano M, Trabattoni D, Lillo F, Ferrante P, Clerici M, Lazzarin A. Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parameter. Perfitsion 2002;17:S47-51.